ADAMTS9-AS2/miR-372/CADM2 was identified as a potential regulatory axis from the ceRNA network for the following reasons: First, ADAMTS9-AS2 and CADM2 were significantly downregulated, while miR-372 was significantly upregulated in GC compared with normal tissue. The gene discussed is ADAMTS9; the disease is gastric cancer.